Back to search results

Kidani Professor of Immuno-Oncology

University of Oxford - Nuffield Department of Medicine in association with Oriel College

Location: Oxford
Salary: Not Specified
Hours: Full Time
Contract Type: Permanent
Placed On: 19th June 2019
Closes: 22nd July 2019
Job Ref: 140722

Available either as a clinical or non-clinical position. If applying as a clinician the professor will be a practicing clinician at NHS consultant/honorary consultant level.

Start date: As soon as possible.

The Kidani Professorship of Immuno-Oncology will be a significant figure in Oxford medicine and will take a leadership role in developing the field of immuno-oncology in the University.

You will be recognised as a leader in immunology, therapeutics and teaching, working across basic and clinical research fields to ensure our existing excellence is maintained.

As well as having a proven track record as a first-class internationally-renowned researcher you will be able to inspire and establish new innovative programmes of research in experimental medicine. You will have proven experience in leading a major research group and securing independent research funding.

There is a high degree of openness to the precise research focus of the appointee. You are welcome to have an informal chat with the Department, please see the Further Particulars for details.

The closing dates for applications is 12.00 noon on Monday 22 July 2019.

Applications are particularly welcome from women and black and minority ethnic candidates, who are under-represented in academic posts in Oxford.

Closing Date: 22-JUL-2019 12:00

We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role:

Subject Area(s):


Job tools
More jobs from University of Oxford

Show all jobs for this employer …

More jobs like this
Join in and follow us

Browser Upgrade Recommended has been optimised for the latest browsers.

For the best user experience, we recommend viewing on one of the following:

Google Chrome Firefox Microsoft Edge